Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure

February 27, 2024

https://www.globenewswire.com/news-release/2024/02/27/2836047/0/en/Manuscript-Discussing-the-Benefit-of-SeaStar-Medical-s-Selective-Cytopheretic-Device-in-Patients-with-Heart-Failure-and-Hyperinflammation-Published-in-European-Journal-of-Heart-Fai.html

Interest continues to grow in developing new strategies to reduce systemic inflammation as a means of improving outcomes in heart failure patients

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.